Abstract
Introduction/BackgroundStandard of care chemotherapy in patients (pts) with advanced ovarian cancer (AOC) is the combination of carboplatin and paclitaxel (C/P). Data from the PRIMA trial has shown a significant benefit...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have